NDC Active Ingredient Insulin Degludec
Active Ingredient Information
What is the usage for Insulin Degludec?
Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.
How many products in the NDC database contain Insulin Degludec?
The NDC database has 12 products with the active ingredient Insulin Degludec. The following table lists all the products that have this active ingredient.
NDC Products with Insulin Degludec
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0169-2550 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-2660 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-2662 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-2911 | Proprietary Name: Xultophy 100/3.6 | (insulin Degludec And Liraglutide) | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
0420-9007 | Proprietary Name: | Degludec | Powder | Novo Nordisk A/s | ACTIVE | ||
50090-3491 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-7077 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-7094 | Proprietary Name: Tresiba | Insulin Degludec | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
52221-127 | Proprietary Name: | Insulin Degludec | Powder | Amphastar Nanjing Pharmaceuticals, Inc. | ACTIVE | ||
73070-400 | Proprietary Name: Insulin Degludec | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk Pharma, Inc. | ACTIVE | |
73070-403 | Proprietary Name: Insulin Degludec | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk Pharma, Inc. | ACTIVE | |
73070-503 | Proprietary Name: Insulin Degludec | Insulin Degludec | Injection, Solution | Subcutaneous | Novo Nordisk Pharma, Inc. | ACTIVE |